Mdr-3 Antibodies

Santa Cruz Biotechnology delivers a wide array of Mdr-3 monoclonal antibodies for advanced research in drug transport and resistance. Mdr-3 Antibodies are optimized for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Mdr-3, also known as P-glycoprotein 3, plays a critical role in the efflux of drugs and xenobiotics across cell membranes, significantly influencing pharmacokinetics and drug resistance in cancer therapy. Understanding the function of Mdr-3 is essential for developing strategies to overcome multidrug resistance in tumors, making Mdr-3 research crucial for both basic and applied studies in pharmacology and toxicology. Researchers can explore drug transport mechanisms through detailed protein expression analysis and localization studies. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of Mdr-3 in various experimental setups. Investigating Mdr-3's role in drug resistance mechanisms can lead to improved therapeutic approaches for cancer treatment. Santa Cruz Biotechnology monoclonal antibodies for Mdr-3 support researchers worldwide in advancing our understanding of drug transport and resistance mechanisms, contributing to the development of more effective cancer treatments.